189 related articles for article (PubMed ID: 34080962)
1. 3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples.
Xie L; Jiang X; Chen Y; Huang C; Chen Y; Liu G; Sun W; Zeng L; Lu R
Comb Chem High Throughput Screen; 2022; 25(8):1304-1313. PubMed ID: 34080962
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the DNA methylome in women with PCOS diagnosed using the new international evidence-based guidelines.
Wang Y; Gao X; Yang Z; Yan X; He X; Guo T; Zhao S; Zhao H; Chen ZJ
Hum Reprod; 2023 Nov; 38(Supplement_2):ii69-ii79. PubMed ID: 37982419
[TBL] [Abstract][Full Text] [Related]
3. A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs.
Wang M; An K; Huang J; Mprah R; Ding H
Front Endocrinol (Lausanne); 2023; 14():1193992. PubMed ID: 37745699
[TBL] [Abstract][Full Text] [Related]
4. Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics.
Liu S; Zhao X; Meng Q; Li B
PLoS One; 2023; 18(10):e0293447. PubMed ID: 37883387
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
[TBL] [Abstract][Full Text] [Related]
6. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
[TBL] [Abstract][Full Text] [Related]
7. Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome.
Qu J; Li B; Qiu M; Wang J; Chen Z; Li K; Teng X
Arch Gynecol Obstet; 2022 Nov; 306(5):1607-1615. PubMed ID: 35904610
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.
Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
Fertil Steril; 2015 Jul; 104(1):145-53.e6. PubMed ID: 25956362
[TBL] [Abstract][Full Text] [Related]
10. Identification potential epigenetic biomarkers of a human immunodeficiency virus/tuberculosis co-infection based on weighted gene co-expression network analysis.
Xu S; Yuan H; Li L; Bai F; Yang K; Zhao L
Microbiol Immunol; 2021 Oct; 65(10):422-431. PubMed ID: 34125446
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
[TBL] [Abstract][Full Text] [Related]
12. Shared diagnostic genes and potential mechanism between PCOS and recurrent implantation failure revealed by integrated transcriptomic analysis and machine learning.
Chen W; Yang Q; Hu L; Wang M; Yang Z; Zeng X; Sun Y
Front Immunol; 2023; 14():1175384. PubMed ID: 37261354
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
15. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
[No Abstract] [Full Text] [Related]
16. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
17. Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure.
Gao Q; Ma C; Meng S; Wang G; Xing Q; Xu Y; He X; Wang T; Cao Y
Front Endocrinol (Lausanne); 2022; 13():946504. PubMed ID: 36060967
[TBL] [Abstract][Full Text] [Related]
18. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome.
Sagvekar P; Kumar P; Mangoli V; Desai S; Mukherjee S
Clin Epigenetics; 2019 Apr; 11(1):61. PubMed ID: 30975191
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome.
Na Z; Guo W; Song J; Feng D; Fang Y; Li D
J Ovarian Res; 2022 Jul; 15(1):80. PubMed ID: 35794640
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
